文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

作者信息

Soubeyran Pierre, Bellera Carine, Goyard Jean, Heitz Damien, Curé Hervé, Rousselot Hubert, Albrand Gilles, Servent Véronique, Jean Olivier Saint, van Praagh Isabelle, Kurtz Jean-Emmanuel, Périn Stéphane, Verhaeghe Jean-Luc, Terret Catherine, Desauw Christophe, Girre Véronique, Mertens Cécile, Mathoulin-Pélissier Simone, Rainfray Muriel

机构信息

Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France; University of Bordeaux, Bordeaux, France.

Clinical and Epidemiological Research unit, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France; INSERM U897 (Institut national de la santé et de la recherche médicale), CIC1401 (Centre d'investigation clinique), Institut Bergonié, Bordeaux, France.

出版信息

PLoS One. 2014 Dec 11;9(12):e115060. doi: 10.1371/journal.pone.0115060. eCollection 2014.


DOI:10.1371/journal.pone.0115060
PMID:25503576
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4263738/
Abstract

BACKGROUND: Geriatric Assessment is an appropriate method for identifying older cancer patients at risk of life-threatening events during therapy. Yet, it is underused in practice, mainly because it is time- and resource-consuming. This study aims to identify the best screening tool to identify older cancer patients requiring geriatric assessment by comparing the performance of two short assessment tools the G8 and the Vulnerable Elders Survey (VES-13). PATIENTS AND METHODS: The diagnostic accuracy of the G8 and the (VES-13) were evaluated in a prospective cohort study of 1674 cancer patients accrued before treatment in 23 health care facilities. 1435 were eligible and evaluable. Outcome measures were multidimensional geriatric assessment (MGA), sensitivity (primary), specificity, negative and positive predictive values and likelihood ratios of the G8 and VES-13, and predictive factors of 1-year survival rate. RESULTS: Patient median age was 78.2 years (70-98) with a majority of females (69.8%), various types of cancer including 53.9% breast, and 75.8% Performance Status 0-1. Impaired MGA, G8, and VES-13 were 80.2%, 68.4%, and 60.2%, respectively. Mean time to complete G8 or VES-13 was about five minutes. Reproducibility of the two questionnaires was good. G8 appeared more sensitive (76.5% versus 68.7%, P =  0.0046) whereas VES-13 was more specific (74.3% versus 64.4%, P<0.0001). Abnormal G8 score (HR = 2.72), advanced stage (HR = 3.30), male sex (HR = 2.69) and poor Performance Status (HR = 3.28) were independent prognostic factors of 1-year survival. CONCLUSION: With good sensitivity and independent prognostic value on 1-year survival, the G8 questionnaire is currently one of the best screening tools available to identify older cancer patients requiring geriatric assessment, and we believe it should be implemented broadly in daily practice. Continuous research efforts should be pursued to refine the selection process of older cancer patients before potentially life-threatening therapy.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c08/4263738/efb044566aef/pone.0115060.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c08/4263738/ecf07be79213/pone.0115060.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c08/4263738/efb044566aef/pone.0115060.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c08/4263738/ecf07be79213/pone.0115060.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c08/4263738/efb044566aef/pone.0115060.g002.jpg

相似文献

[1]
Screening for vulnerability in older cancer patients: the ONCODAGE Prospective Multicenter Cohort Study.

PLoS One. 2014-12-11

[2]
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancer.

J Geriatr Oncol. 2022-6

[3]
A Questionnaire Study to Assess the Value of the Vulnerable Elders Survey, G8, and Predictors of Toxicity as Screening Tools for Frailty and Toxicity in Geriatric Cancer Patients.

Oncol Res Treat. 2016-3-30

[4]
Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.

Oncologist. 2016-2

[5]
Screening for frailty among older patients with cancer that qualify for abdominal surgery.

J Geriatr Oncol. 2015-1

[6]
Agreement analysis between three different short geriatric screening scales in patients undergoing chemotherapy for solid tumors.

J Cancer Res Ther. 2017

[7]
Performance of two geriatric screening tools in older patients with cancer.

J Clin Oncol. 2013-11-25

[8]
Prospective comparison of the value of CARG, G8, and VES-13 toxicity tools in predicting chemotherapy-related toxicity in older Turkish patients with cancer.

J Geriatr Oncol. 2022-7

[9]
Performance of the Vulnerable Elders Survey 13 screening tool in identifying cancer treatment modification after geriatric assessment in pre-treatment patients: A retrospective analysis.

J Geriatr Oncol. 2018-11-9

[10]
PPT and VES-13 in elderly patients with cancer: evaluation in multidimensional geriatric assessment and prediction of survival.

J Geriatr Oncol. 2014-10-1

引用本文的文献

[1]
Systemic therapy strategies for elderly patients with gastric cancer.

Ther Adv Med Oncol. 2025-8-16

[2]
The prognostic role of Geriatric 8 in patients with cancer: a meta-analysis and systematic review.

Oncologist. 2025-6-4

[3]
Leveraging Digital Twins for Stratification of Patients with Breast Cancer and Treatment Optimization in Geriatric Oncology: Multivariate Clustering Analysis.

JMIR Cancer. 2025-5-23

[4]
Geriatric Assessment and Management, Prehabilitation and Rehabilitation for Older Aldults with Non-Colorectal Digestive Cancers.

Cancers (Basel). 2025-5-7

[5]
Efficacy and safety of oxaliplatin-based chemotherapy as first-line treatment in elderly patients with metastatic colorectal cancer: a meta-analysis.

Front Oncol. 2025-4-7

[6]
Geriatric Assessment Tools in Head and Neck Radiation Oncology: An Unmet Need.

Cureus. 2025-3-3

[7]
Prognostic Value of G8 Geriatric Screening and Meet-URO Scores in Metastatic Renal Cell Carcinoma Patients Receiving First-Line Ipilimumab-Nivolumab Combination Immunotherapy.

Technol Cancer Res Treat. 2025

[8]
Prognostic Factors for Free Flap Failure in Head and Neck Reconstruction.

Head Neck. 2025-7

[9]
Distribution of Geriatric 8 screening tool scores in elderly and non-elderly patients with cancer.

Int J Clin Oncol. 2025-3

[10]
Impact of an Enhanced Recovery After Surgery (ERAS) program on the management of complications after laparoscopic or robotic colectomy for cancer.

Ann Coloproctol. 2024-10

本文引用的文献

[1]
Functional decline in older patients with cancer receiving first-line chemotherapy.

J Clin Oncol. 2013-9-23

[2]
Geriatric oncology clinics on the rise.

J Natl Cancer Inst. 2013-5-1

[3]
Screening methods for geriatric frailty.

Lancet Oncol. 2013-1

[4]
Evaluation of the cardiovascular health study (CHS) instrument and the Vulnerable Elders Survey-13 (VES-13) in elderly cancer patients. Are we still missing the right screening tool?

Ann Oncol. 2012-10-7

[5]
Screening elderly cancer patients for disabilities: evaluation of study of osteoporotic fractures (SOF) index and comprehensive geriatric assessment (CGA).

Ann Oncol. 2012-10-5

[6]
Frailty screening methods for predicting outcome of a comprehensive geriatric assessment in elderly patients with cancer: a systematic review.

Lancet Oncol. 2012-10

[7]
Predictors of early death risk in older patients treated with first-line chemotherapy for cancer.

J Clin Oncol. 2012-4-16

[8]
Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA).

Lancet Oncol. 2012-3-30

[9]
Biological, clinical, and psychosocial correlates at the interface of cancer and aging research.

J Natl Cancer Inst. 2012-3-27

[10]
Screening older cancer patients: first evaluation of the G-8 geriatric screening tool.

Ann Oncol. 2012-1-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索